Vicarious Surgical RBOT
OTC RBOT
$0.05 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Vicarious Surgical (RBOT) Cash from Financing Activities (2020 - 2025)

Vicarious Surgical's (RBOT) quarterly Cash from Financing Activities came in at $26000.0 in Q3 2025, up 8.33% quarter-over-quarter from $24000.0 in Q2 2025.

Analysis

Vicarious Surgical (RBOT) Cash from Financing Activities (2020 - 2025) Analysis & Trends

Vicarious Surgical (RBOT) has reported Cash from Financing Activities for 6 consecutive years, with $26000.0 the latest figure, recorded in Q3 2025.

  • On a quarterly basis, Cash from Financing Activities changed N/A year-over-year to $26000.0 in Q3 2025; TTM through Sep 2025 was $73000.0, a 102.78% increase from a year earlier, with the FY2024 full-year figure at $8000.0, down 99.98% from the prior year.
  • Cash from Financing Activities was $26000.0 for Q3 2025 at Vicarious Surgical, up from $24000.0 in the prior quarter.
  • Over five years, Cash from Financing Activities peaked at $191.1 million in Q3 2021 and troughed at -$486000.0 in Q4 2021.
  • A 5-year average of $14.5 million and a median of $59000.0 in 2022 frame the typical range for Cash from Financing Activities.
  • Across the five-year window, Cash from Financing Activities slumped 100.14% in 2021 and soared 44133.0% in 2023, its largest moves.
  • Over 5 years, Cash from Financing Activities stood at -$486000.0 in 2021, then surged by 1913.17% to $8.8 million in 2022, then sank by 99.61% to $34000.0 in 2023, then sank by 82.35% to $6000.0 in 2024, then surged by 333.33% to $26000.0 in 2025.
  • The last three Cash from Financing Activities figures came in at $26000.0 (Q3 2025), $24000.0 (Q2 2025), and $17000.0 (Q1 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Abbott Laboratories 187.42 Bn 182.47 Bn 7.27 Bn -3.52 Bn
2 Intuitive Surgical 129.78 Bn 124.69 Bn 1.96 Bn -287.90 Mn
3 Medtronic 120.53 Bn 112.33 Bn 6.34 Bn -343.00 Mn
4 Stryker 116.28 Bn 112.80 Bn 4.50 Bn -95.00 Mn
5 Boston Scientific 69.29 Bn 68.99 Bn 3.85 Bn -410.00 Mn
6 Edwards Lifesciences 51.83 Bn 47.68 Bn 1.35 Bn -300,000.00
7 Alcon 34.36 Bn 32.91 Bn 1.68 Bn -510.00 Mn
8 Dexcom 33.17 Bn 31.23 Bn 830.00 Mn -607.30 Mn
9 Steris 21.90 Bn 21.43 Bn 684.20 Mn -213.50 Mn
10 Vicarious Surgical 476,777.11 -14.56 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 26,000.00
Jun 30, 2025 24,000.00
Mar 31, 2025 17,000.00
Dec 31, 2024 6,000.00
Mar 31, 2024 2,000.00
Dec 31, 2023 34,000.00
Sep 30, 2023 44.23 Mn
Jun 30, 2023 162,000.00
Mar 31, 2023 273,000.00
Dec 31, 2022 8.81 Mn
Sep 30, 2022 100,000.00
Jun 30, 2022 59,000.00
Mar 31, 2022 174,000.00
Dec 31, 2021 -486,000.00
Sep 30, 2021 191.06 Mn
Jun 30, 2021 39,000.00
Mar 31, 2021 1.55 Mn
Dec 31, 2020 346.52 Mn
Sep 30, 2020 346.52 Mn